Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Ann Epidemiol. 2023 Oct 29;88:15–22. doi: 10.1016/j.annepidem.2023.10.008

Table 1.

Baseline characteristics of UK Biobank participants by inflammatory bowel disease status at baseline assessmenta (n=502,369)

IBD
Characteristics Total Yes (N=5,789) No (N=496,624) UC (N=4,166) CD (N=2,112)
Age at assessment, years, mean ± SD 56.5 ± 8.1 57.3 ± 7.9 56.5 ± 8.1 57.6 ± 7.8 56.6 ± 8.0
Townsend deprivation index, mean ± SD −1.3 ± 3.1 −1.3 ± 3.1 −1.3 ± 3.1 −1.31 ± 3.0 −1.1 ± 3.2
Sex, n (%)
Male 229,068 (45.6) 2,752 (47.5) 226,316 (45.6) 2,050 (49.1) 944 (44.6)
Female 273,301 (54.0) 3,047 (52.5) 270,254 (54.4) 2,124 (50.9) 1,171 (55.4)
Race, n (%)
Asian 11,452 (2.3) 125 (2.2) 11,327 (2.3) 98 (2.4) 41 (1.9)
Black 8,058 (1.6) 38 (0.7) 8,020 (1.6) 26 (0.6) 18 (0.9)
Mixed race 2,953 (0.6) 19 (0.3) 2,934 (0.6) 16 (0.4) <5 (0.1)
Other races 4,555 (0.9) 34 (0.6) 4,521 (0.9) 28 (0.7) 11 (0.5)
White 472,573 (94.1) 5,552 (95.7) 467,021 (94.1) 3,981 (95.4) 2,032 (96.1)
Assessment center, n (%)
England 445,728 (88.7) 5,042 (87.0) 440,686 (88.8) 3,625 (86.9) 1,831 (86.6)
Scotland 35,837 (7.1) 488 (8.4) 35,349 (7.1) 359 (8.6) 179 (8.5)
Wales 20,804 (4.1) 269 (4.6) 20,535 (4.1) 190 (4.6) 105 (5.0)
BMI, kg/m 2 , n (%)
<18.5 2,626 (0.5) 45 (0.8) 2,581 (0.5) 22 (0.5) 28 (1.3)
18.5 to <25.0 162,352 (32.3) 1,955 (33.7) 160,397 (32.3) 1,351 (32.5) 750 (35.5)
25.0 to <30.0 212,062 (42.2) 2,485 (42.9) 209,577 (42.2) 1,808 (43.3) 898 (42.5)
30.0 to <35.0 87,534 (17.4) 929 (16.0) 86,605 (17.4) 697 (16.7) 297 (14.0)
 ≥35.0 34,688 (6.9) 344 (5.9) 34,344 (6.9) 257 (6.2) 130 (6.2)
Overall health rating, n (%)
Excellent 81,833 (16.3) 396 (6.8) 81,437 (16.4) 303 (7.3) 107 (5.1)
Good 288,948 (57.5) 2,699 (46.5) 286,249 (57.7) 2,032 (48.7) 855 (40.4)
Fair 105,333 (21.0) 1,961 (33.8) 103,372 (20.8) 1,357 (32.5) 788 (37.3)
Poor 22,768 (4.5) 706 (12.2) 22,062 (4.4) 453 (10.9) 349 (16.5)
Smoking, n (%)
Never 273,449 (54.4) 2,727 (47.0) 270,722 (54.5) 2,015 (48.3) 944 (44.6)
Former 173,009 (34.4) 2,482 (42.8) 170,527 (34.3) 1,836 (44.0) 850 (40.2)
Current 52,964 (10.5) 562 (9.7) 52,399 (10.6) 302 (7.2) 311 (14.7)
Alcohol drinking, n (%)
Never 22,379 (4.5) 293 (5.1) 22,086 (4.5) 207 (5.0) 127 (6.0)
Former 18,093 (3.6) 298 (5.1) 17,795 (3.6) 199 (4.8) 119 (5.6)
Current, <3 drink/month 113,825 (22.7) 1,465 (25.3) 112,360 (22.6) 1001 (24.0) 586 (27.7)
Current, <1 drink/day 124,784 (24.8) 1,383 (23.9) 123,401 (24.9) 998 (23.9) 499 (23.6)
Current, 1 to 3 drink/day 179,516 (35.7) 1,920 (33.1) 177,594 (35.8) 1,426 (34.2) 642 (30.4)
Current, >3 drink/day 41,971 (8.4) 420 (7.2) 41,551 (8.4) 327 (7.8) 133 (6.3)
Physical activity, days/week, n (%)
0 52,690 (10.5) 701 (12.1) 51,989 (10.5) 498 (11.9) 266 (12.6)
1–2 63,530 (12.7) 756 (13.0) 62,774 (12.6) 506 (12.1) 314 (14.9)
3–4 81,860 (16.3) 934 (16.1) 80,926 (16.3) 681 (16.3) 326 (15.4)
>=5 261,669 (52.1) 2,852 (49.2) 258,817 (52.1) 2,100 (50.3) 996 (47.1)
Aspirin use, n (%) 69,642 (13.9) 818 (14.1) 68,824 (13.9) 620 (14.9) 272 (12.9)
Ibuprofen use, n (%) 73,279 (14.6) 655 (11.3) 72,624 (14.6) 454 (10.9) 246 (11.6)
Laxative use, n (%) 14,888 (3.0) 189 (3.3) 14,699 (3.0) 134 (3.2) 69 (3.3)
Diabetes, n (%) 21,719 (4.3) 307 (5.3) 21,412 (4.3) 226 (5.4) 109 (5.2)
Hypertension, n (%) 130,956 (26.1) 1,581 (27.3) 129,375 (26.1) 1,129 (27.1) 594 (28.1)
Asthma, n (%) 58,258 (11.6) 802 (13.8) 57,456 (11.6) 561 (13.4) 309 (14.6)
Tuberculosis, n (%) 2,542 (0.5) 42 (0.7) 2,500 (0.5) 28 (0.7) 18 (0.9)

NOTE: inflammatory bowel diseases (IBD); ulcerative colitis (CD); Crohn’s disease (CD); body mass index (BMI).

a

Numbers may not sum to n=502,369, and percentages may not sum to 100% owing to missing data.

b

Physical activity measured by number of days/week of >10 min of moderate or vigorous activity.